Colorectal cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
2003, Colorectal Cancer, 198
Russo, 2004, Digestive and liver diseases statistics, 2004, Gastroenterology, 126, 1448, 10.1053/j.gastro.2004.01.025
Mitchell, 2004, Accuracy of reporting of family history of colorectal cancer, Gut, 53, 291, 10.1136/gut.2003.027896
Half, 2004, Clinical management of hereditary colorectal cancer syndromes, Curr Opin Gastroenterol, 20, 32, 10.1097/00001574-200401000-00008
Sieber, 2003, Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH, N Engl J Med, 348, 791, 10.1056/NEJMoa025283
Venesio, 2004, High frequency of MYH gene mutations in a subset of patients with familial adenomatous polyposis, Gastroenterology, 126, 1681, 10.1053/j.gastro.2004.02.022
BŸlow, 2004, Duodenal adenomatosis in familial adenomatous polyposis, Gut, 53, 381, 10.1136/gut.2003.027771
Parc, 2004, Long-term outcome of familial adenomatous polyposis patients after restorative coloproctectomy, Ann Surg, 239, 378, 10.1097/01.sla.0000114216.90947.f6
Grady, 2003, Genetic testing for high-risk colon cancer patients, Gastroenterology, 124, 1574, 10.1016/S0016-5085(03)00376-7
Bisgaard, 2004, Familial adenomatous polyposis patients without an identified APC germline mutation have a severe phenotype, Gut, 53, 266, 10.1136/gut.2003.019042
Vasen, 1999, New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC, Gastroenterology, 116, 1453, 10.1016/S0016-5085(99)70510-X
Bandipalliam, 2004, Clinical presentation correlates with the type of mismatch repair gene involved in hereditary nonpolyposis colon cancer, Gastroenterology, 126, 936, 10.1053/j.gastro.2004.01.038
Umar, 2004, Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability, J Natl Cancer Inst, 96, 261, 10.1093/jnci/djh034
Itzkowitz, 2004, Diagnosis and management of dysplasia in patients with inflammatory bowel disease, Gastroenterology, 126, 1634, 10.1053/j.gastro.2004.03.025
Krok, 2004, Colorectal cancer in inflammatory bowel disease, Curr Opin Gastoenterol, 20, 43, 10.1097/00001574-200401000-00009
Kahi, 2004, Current and future trends in colorectal cancer screening, Cancer Met Rev, 23, 137, 10.1023/A:1025871231346
Winawer, 2003, Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence, Gastroenterology, 124, 544, 10.1053/gast.2003.50044
Weir, 2003, Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention and control, J Natl Cancer Inst, 95, 1276, 10.1093/jnci/djg040
Hurlstone, 2004, Detecting diminutive colorectal lesions at colonoscopy: a randomised controlled trial of pan-colonic versus targeted chromoscopy, Gut, 53, 376, 10.1136/gut.2003.029868
Kiesslich, 2003, Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis, Gastroenterology, 124, 880, 10.1053/gast.2003.50146
Kiesslich, 2004, Endoscopic mucosal resection: an evolving therapeutic strategy for non-polypoid colorectal neoplasia, Gut, 53, 1222, 10.1136/gut.2004.043281
Kiesslich, 2004, Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo, Gastroenterology, 127, 706, 10.1053/j.gastro.2004.06.050
Rosenblatt, 2004, Serum proteomics in cancer diagnosis and management, Ann Rev Med, 55, 97, 10.1146/annurev.med.55.091902.105237
Cruz-Correa, 2004, Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition, Gastroenterology, 126, 964, 10.1053/j.gastro.2003.12.051
Renehan, 2004, Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis, Lancet, 363, 1346, 10.1016/S0140-6736(04)16044-3
Hawk, 2004, Colorectal Cancer Chemoprevention: an overview of the science, Gastroenterology, 126, 1423, 10.1053/j.gastro.2004.03.002
Asano, 2004, Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review, Dis Colon Rectum, 47, 665, 10.1007/s10350-003-0111-9
Brennan, 2003, Pre-emptive surgery and increasing demands for technical perfection, Br J Surg, 90, 3, 10.1002/bjs.4001
Lynch, 2002, The genetic pathogenesis of colorectal cancer, Hematol Oncol Clin N Am, 16, 775, 10.1016/S0889-8588(02)00029-1
Kondo, 2004, Epigenetic changes in colorectal cancer, Cancer Met Rev, 23, 29, 10.1023/A:1025806911782
Calvert, 2002, The genetics of colorectal cancer, Ann Intern Med, 137, 603, 10.7326/0003-4819-137-7-200210010-00012
Jass, 2002, Emerging concepts in colorectal neoplasia, Gastroenterology, 123, 862, 10.1053/gast.2002.35392
Soetikno, 2003, Flat and depressed colorectal neoplasms, Curr Opin Gastroenterol, 19, 69, 10.1097/00001574-200301000-00012
Itzkowitz, 2004, Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation, Am J Physiol Gastrointest Liver Physiol, 287, G7, 10.1152/ajpgi.00079.2004
Rao, 2004, Role of cylooxygenase-2 in the angiogenesis of colorectal cancer, Int J Colorectal Dis, 19, 1, 10.1007/s00384-003-0511-2
Sinicrope, 2004, Role of cyclooxygenase-2 in colorectal cancer, Cancer Met Rev, 23, 63, 10.1023/A:1025863029529
Harman, 2004, Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis, Nat Med, 10, 481, 10.1038/nm1026
Wang, 2004, Mutational analysis of the tyrosine phosphatome in colorectal cancers, Science, 304, 1164, 10.1126/science.1096096
Jung, 2004, Loss of activin type 2 protein expression in microsatellite unstable colon cancers, Gastroenterology, 126, 654, 10.1053/j.gastro.2004.01.008
Samuels, 2004, High frequency of mutations of the PIK3CA gene in human cancers, Science, 304, 554, 10.1126/science.1096502
Rajagopalan, 2004, Inactivation of hCDC4 can cause chromosomal instability, Nature, 428, 77, 10.1038/nature02313
Urbach, 2004, Does it matter what a hospital is “high volume” for? Specificity of hospital volume-outcome associations for surgical procedures: analysis of administrative data, BMJ, 328, 737, 10.1136/bmj.38030.642963.AE
Callahan, 2003, Influence of surgical subspecialty training on in-hospital mortality for gastrectomy and colectomy patients, Ann Surg, 238, 629, 10.1097/01.sla.0000089855.96280.4a
Dimick, 2003, Hospital volume and surgical outcomes for elderly patients with colorectal cancer in the United States, J Surg Res, 114, 50, 10.1016/S0022-4804(03)00207-5
Hodgson, 2003, Relation of hospital volume to colostomy rates and survival for patients with rectal cancer, J Natl Cancer Inst, 95, 708, 10.1093/jnci/95.10.708
Birkmeyer, 2002, Hospital volume and surgical mortality in the united states, N Engl J Med, 346, 1128, 10.1056/NEJMsa012337
Hannan, 2002, The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer, Surgery, 131, 6, 10.1067/msy.2002.120238
Schrag, 2000, Influence of hospital procedure volume on outcomes following surgery for colon cancer, JAMA, 284, 3028, 10.1001/jama.284.23.3028
Harmon, 1999, Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection, Ann Surg, 230, 404, 10.1097/00000658-199909000-00013
Rabeneck, 2004, Surgical volume and long-term survival following surgery for colorectal cancer in the veterans affairs health-care system, Am J Gastroenterol, 99, 668, 10.1111/j.1572-0241.2004.04135.x
Finlayson, 2003, Effect of hospital volume on life expectancy after selected cancer operations in older adults: a decision analysis, J Am Coll Surg, 196, 410, 10.1016/S1072-7515(02)01753-2
LeVoyer, 2003, Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089, J Clin Oncol, 21, 2912, 10.1200/JCO.2003.05.062
Sobin, 2002
Compton, 2003, Colorectal carcinoma: diagnostic, prognostic, and molecular features, Mod Pathol, 16, 376, 10.1097/01.MP.0000062859.46942.93
Nagtegaal, 2002, Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control, J Clin Oncol, 20, 1729, 10.1200/JCO.2002.07.010
Gill, 2004, Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?, J Clin Oncol, 22, 1797, 10.1200/JCO.2004.09.059
Greene, 2002, A new TNM staging strategy for node-positive (stage III) colon cancer, Ann Surg, 236, 416, 10.1097/00000658-200210000-00003
Greene, 2004, New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: an analysis, J Clin Oncol, 22, 1778, 10.1200/JCO.2004.07.015
Gunderson, 2004, Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis, J Clin Oncol, 22, 1785, 10.1200/JCO.2004.08.173
Staib, 2002, Surgery of colorectal cancer: surgical morbidity and five- and ten-year results in 2400 patients-monoinstitutional experience, World J Surg, 26, 59, 10.1007/s00268-001-0182-5
Kahlenberg, 2003, Molecular prognosis in colorectal cancer, Surg Oncol, 12, 173, 10.1016/S0960-7404(03)00006-9
Galizia, 2004, Determination of molecular marker expression can predict clinical outcome in colon carcinomas, Clin Cancer Res, 10, 3490, 10.1158/1078-0432.CCR-0960-03
Parc, 2004, Prognostic significance of microsatellite instability determine immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancer, Gut, 53, 371, 10.1136/gut.2003.019190
Allegra, 2003, Prognostic value of thymidylate synthase, ki-67, and p53 in patients with Dukes' B and C colon cancer: a national cancer institute-national surgical adjuvant breast and bowel project collaborative study, J Clin Oncol, 21, 241, 10.1200/JCO.2003.05.044
Rau, 2003, Dynamic expression profile of a WAF/CIP1 and ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy, J Clin Oncol, 21, 3391, 10.1200/JCO.2003.07.077
Diep, 2003, Genetic tumor markers with prognostic impact in Dukes' Stages B and C colorectal cancer patients, J Clin Oncol, 21, 820, 10.1200/JCO.2003.05.190
Gertler, 2004, Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma, J Clin Oncol, 22, 1807, 10.1200/JCO.2004.09.160
Klump, 2004, Molecular lesions in colorectal cancer: impact on prognosis?, Int J Colorectal Dis, 19, 23, 10.1007/s00384-003-0499-7
Graziano, 2003, Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough?, Ann Oncol, 14, 1026, 10.1093/annonc/mdg284
Popart, 2004, Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis, J Clin Oncol, 22, 529, 10.1200/JCO.2004.05.064
Bertucci, 2004, Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters, Oncogene, 23, 1377, 10.1038/sj.onc.1207262
Wang, 2004, Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer, Ann Surg, 22, 1564
Feezor, 2002, Significance of micrometastases in colorectal cancer, Ann Surg Oncol, 9, 944, 10.1007/BF02574511
Kienle, 2001, Minimal residual disease in gastrointestinal cancer, Semin Surg Oncol, 20, 282, 10.1002/ssu.1046
Kienle, 2003, Decreased detection rate of disseminated tumor cells of rectal cancer patients after preoperative chemoradiation: a first step towards a molecular surrogate marker for neoadjuvant treatment in colorectal cancer, Ann Surg, 238, 324, 10.1097/01.sla.0000086547.27615.e6
Koch M, Kienle P, Hinz U, et al. Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases. Ann Surg (in press).
Mc Andrew, 1999, Efficacy of routine preoperative computed tomography scans in colon cancer, Am Surg, 65, 205, 10.1177/000313489906500302
Goh, 2004, Local radiological staging of rectal cancer, Clin Radiol, 59, 215, 10.1016/j.crad.2003.08.013
Brown, 2004, High-resolution MRI of the anatomy important in total mesorectal excision of the rectum, AJR, 182, 431, 10.2214/ajr.182.2.1820431
Brown, 2004, Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging?, Br J Cancer, 91, 23, 10.1038/sj.bjc.6601871
Cohade, 2003, Direct comparison of 18 F-FDG PET and PET/CT in patients with colorectal cancer, J Nucl Med, 44, 1797
Kinkel, 2002, Detection of hepatic metastases from cancers of the gastrointestinal tract by using non-invasive imaging methods (US, CT, MRI imaging, PET): a meta analysis, Radiology, 224, 748, 10.1148/radiol.2243011362
Cecil, 2004, Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer, Dis Colon Rectum, 47, 1145, 10.1007/s10350-004-0086-6
Simunovic, 2003, Optimal preoperative assessment and surgery for rectal cancer may greatly limit the need for radiotherapy, Br J Surg, 90, 999, 10.1002/bjs.4210
Ueno, 2004, Preoperative parameters expanding the indication of sphincter preserving surgery in patients with advanced low rectal cancer, Ann Surg, 239, 34, 10.1097/01.sla.0000103070.13030.eb
Engel, 2003, Quality of life in rectal cancer patients, Ann Surg, 238, 203, 10.1097/01.sla.0000080823.38569.b0
Z'graggen, 2001, A new surgical concept for rectal replacement after low anterior resection: the transverse coloplasty pouch, Ann Surg, 234, 780, 10.1097/00000658-200112000-00009
Machado, 2003, Similar outcome after colonic pouch and side-to-end anastomosis in low anterior resection for rectal cancer: a prospective randomized trial, Ann Surg, 238, 214, 10.1097/01.sla.0000080824.10891.e1
FŸrst, 2003, Colonic j-pouch vs coloplasty following resection of distal rectal cancer, Dis Colon Rectum, 46, 1161, 10.1007/s10350-004-6707-x
Jesus, 2003, Prophylactic routine anastomotic drainage in elective colorectal surgery: systematic review and meta-analysis, Rev Assoc Med Bras, 49, 214, 10.1590/S0104-42302003000200044
Cheatham, 1995, A meta-analysis of selective versus routine nasogastric decompression after elective laparotomy, Ann Surg, 221, 469, 10.1097/00000658-199505000-00004
Guenaga, 2003, Mechanical bowel preparation for elective colorectal surgery, Cochrane Database Syst Rev, 2, CD001544
Brandstrup, 2003, Effects of intravenous fluid restriction of postoperative complications: comparison of two perioperative fluid regimes, Ann Surg, 238, 641, 10.1097/01.sla.0000094387.50865.23
Kehlet, 2003, Anaesthesia, surgery, and challenges in postoperative recovery, Lancet, 362, 1921, 10.1016/S0140-6736(03)14966-5
Basse, 2004, Colonic surgery with accelerated rehabilitation or conventional care, Dis Colon Rectum, 47, 271, 10.1007/s10350-003-0055-0
Anderson, 2003, Randomized clinical trial of multimodal optimization and standard perioperative surgical care, Br J Surg, 90, 1497, 10.1002/bjs.4371
2004, A comparison of laparoscopically assisted and open colectomy for colon cancer, N Engl J Med, 350, 2050, 10.1056/NEJMoa032651
Janson, 2004, Randomized clinical trial of the costs of open and laparoscopic surgery for colonic cancer, Br J Surg, 91, 409, 10.1002/bjs.4469
Kiran, 2004, Operative blood loss and use of blood products after laparoscopic and conventional open colorectal operations, Arch Surg, 139, 39, 10.1001/archsurg.139.1.39
Leung, 2004, Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial, Lancet, 363, 1187, 10.1016/S0140-6736(04)15947-3
Basse, 2003, Gastrointestinal transit after laparoscopic vs open colonic resection, Surg Endosc, 17, 1919, 10.1007/s00464-003-9013-0
Delaney, 2003, Case-matched comparison of clinical and financial outcome after laparoscopic or open colorectal surgery, Ann Surg, 238, 67, 10.1097/01.sla.0000074967.53451.22
Lacy, 2002, Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial, Lancet, 359, 2224, 10.1016/S0140-6736(02)09290-5
Weeks, 2002, Short-term quality-of-live outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer, JAMA, 287, 321, 10.1001/jama.287.3.321
Saha, 2004, Sentinel lymph node mapping technique in colon cancer, Semin Oncol, 31, 374, 10.1053/j.seminoncol.2004.03.008
Bembeneck, 2004, Sentinel lymph node biopsy in rectal cancer-not yet ready for routine use, Surgery, 135, 498, 10.1016/j.surg.2003.10.004
Verwaal, 2003, Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer, J Clin Oncol, 21, 3737, 10.1200/JCO.2003.04.187
Glehen, 2004, Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin, Br J Surg, 91, 747, 10.1002/bjs.4473
Shen, 2004, Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma, Ann Surg Oncol, 11, 178, 10.1245/ASO.2004.05.009
Verwaal, 2004, Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraabdominal chemotherapy, Br J Surg, 91, 739, 10.1002/bjs.4516
Gunderson, 2003, Rectal cancer: preoperative versus postoperative irradiation as a component of adjuvant treatment, Semin Rad Oncol, 13, 419, 10.1016/S1053-4296(03)00073-0
Kapiteijn, 2001, Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer, N Engl J Med, 345, 638, 10.1056/NEJMoa010580
Marijnen, 2001, No downstaging after short-term preoperative radiotherapy in rectal cancer patients, J Clin Oncol, 19, 1976, 10.1200/JCO.2001.19.7.1976
Marijnen, 2003, Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial, Int J Radiat Oncol Biol Phys, 55, 1311, 10.1016/S0360-3016(02)04291-8
van den Brink, 2004, Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: the dutch colorectal cancer group, J Clin Oncol, 22, 244, 10.1200/JCO.2004.04.198
Hermanek, 2004, Pre-operative radiotherapy for rectal carcinoma? Has the case really been made for short course pre-operative radiotherapy if surgical standards for rectal carcinoma are optimal?, Colorectal Dis, 6, 10, 10.1111/j.1463-1318.2004.00569.x
Sauer, 2004, Preoperative versus postoperative chemoradiotherapy for rectal cancer, N Engl J Med, 351, 1731, 10.1056/NEJMoa040694
Gerard, 2004, Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the Lyon R98-02 randomized trial, J Clin Oncol, 22, 2404, 10.1200/JCO.2004.08.170
Bosset, 2004, Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC radiotherapy group, Eur J Cancer, 40, 219, 10.1016/j.ejca.2003.09.032
Rŝdel, 2003, Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer, J Clin Oncol, 21, 3098, 10.1200/JCO.2003.02.505
Martenson, 2004, Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130, J Clin Oncol, 22, 3277, 10.1200/JCO.2004.01.029
Benson, 2004, American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer, J Clin Oncol, 22, 3408, 10.1200/JCO.2004.05.063
Figueredo, 2004, Adjuvant therapy for stage II colon cancer: a systematic review from the cancer care Ontario program in evidence-based care's gastrointestinal cancer disease site group, J Clin Oncol, 22, 3395, 10.1200/JCO.2004.03.087
Andre, 2004, Oxaliplatin, Fluorouracil, and Leucovorin as adjuvant treatment for colon cancer, N Engl J Med, 350, 2343, 10.1056/NEJMoa032709
Saltz, 2004, Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALBG C89803), Proc Am Soc Clin Oncol, 3500, 10.1200/jco.2004.22.14_suppl.3500
Cassidy, 2004, Capecitabine versus bolus 5-fluorouracil/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT study): efficacy results of a phase III trial, Proc Am Soc Clin Oncol, 3509, 10.1200/jco.2004.22.14_suppl.3509
Punt, 2002, Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study, Lancet, 360, 671, 10.1016/S0140-6736(02)09836-7
Labianca, 2004, Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinoma, J Natl Cancer Inst, 96, 750, 10.1093/jnci/djh132
Nelson, 2004, A systematic review of hepatic artery chemotherapy after hepatic resection of colorectal cancer metastatic to the liver, Dis Colon Rectum, 47, 739, 10.1007/s10350-003-0113-7
Fernandez, 2004, Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by position emission tomography with F-18 fluorodeoxyglucose (FDG-PET), Ann Surg, 240, 438, 10.1097/01.sla.0000138076.72547.b1
Adam, 2004, Hepatic colorectal metastases: methods of improving resectability, Surg Clin N Am, 84, 659, 10.1016/j.suc.2003.12.005
Tournigand, 2004, FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomised GERCOR study, J Clin Oncol, 22, 229, 10.1200/JCO.2004.05.113
Goldberg, 2004, A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer, J Clin Oncol, 22, 23, 10.1200/JCO.2004.09.046
Sobrero, 2004, Scheduling of fluorouracil: a forget-me-not in the jungle of doublets, J Clin Oncol, 22, 4, 10.1200/JCO.2004.11.974
Grothey, 2004, Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment, J Clin Oncol, 22, 1209, 10.1200/JCO.2004.11.037
van Cutsem, 2004, Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised trials, Br J Cancer, 90, 1190, 10.1038/sj.bjc.6601676
Hurwitz, 2004, Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer, N Engl J Med, 350, 2335, 10.1056/NEJMoa032691
Cunningham, 2004, Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer, N Engl J Med, 351, 337, 10.1056/NEJMoa033025
Schrag, 2004, The price tag on progress: chemotherapy for colorectal cancer, N Engl J Med, 351, 317, 10.1056/NEJMp048143
Mayer, 2004, Two steps forward in the treatment of colorectal cancer, N Engl J Med, 350, 2406, 10.1056/NEJMe048098
Erlichman, 2004, New treatment options for colorectal cancer, N Engl J Med, 351, 391, 10.1056/NEJMe048151
Kerr, 2003, Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial, Lancet, 361, 368, 10.1016/S0140-6736(03)12388-4
Chan, 2004, Hepatic arterial chemotherapy for colorectal cancer liver metastases: a review of advances in 2003, Curr Opin Oncol, 16, 378, 10.1097/01.cco.0000126577.04727.e9
Diaz-Rubio, 2004, New chemotherapeutic advances in pancreatic, colorectal, and gastric cancers, Oncologist, 9, 282, 10.1634/theoncologist.9-3-282
Braun, 2004, New systemic frontline treatment for metastatic colorectal carcinoma, Cancer, 100, 1558, 10.1002/cncr.20154
Koehne, 2004, COX-2 inhibition and colorectal cancer, Semin Oncol, 31, 12, 10.1053/j.seminoncol.2004.03.041
Ribic, 2003, Tumor microsatellite-instability status as predictor of benefit from fluorouracil-based adjuvant chemotherapy for colorectal cancer, N Engl J Med, 349, 247, 10.1056/NEJMoa022289
Carethers, 2004, Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer, Gastroenterology, 126, 394, 10.1053/j.gastro.2003.12.023
Popat, 2004, Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis, J Clin Oncol, 22, 529, 10.1200/JCO.2004.05.064
Adlard, 2002, Prediction of the response of colorectal cancer to systemic therapy, Lancet Oncol, 3, 75, 10.1016/S1470-2045(02)00648-4
Pfister, 2004, Surveillance strategies after curative treatment of colorectal cancer, N Engl J Med, 350, 2375, 10.1056/NEJMcp010529
Renehan, 2002, Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials, BMJ, 324, 1, 10.1136/bmj.324.7341.813
Jeffery, 2002, Follow-up strategies for patients treated for non-metastatic colorectal cancer (Cochrane Review), Cochrane Database Syst Rev, 1, CD002200
Figueredo, 2003, Follow-up of patients with curatively resected colorectal cancer: a practice guideline, BMC Cancer, 3, 26, 10.1186/1471-2407-3-26
Renehan, 2004, Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer, BMJ, 328, 81, 10.1136/bmj.328.7431.81
Chau, 2004, The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer, J Clin Oncol, 22, 1420, 10.1200/JCO.2004.05.041
Johnson, 2004, Follow-up for patients with colorectal cancer after curative-intent primary treatment, J Clin Oncol, 22, 1363, 10.1200/JCO.2004.01.948